Agios Pharmaceuticals AGIO
$ 55.72
2.01%
Quarterly report 2024-Q3
added 10-31-2024
Agios Pharmaceuticals General and Administrative Expenses 2011-2024 | AGIO
Annual General and Administrative Expenses Agios Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
120 M | 122 M | 121 M | 115 M | 132 M | 114 M | 71.1 M | 50.7 M | 36 M | 19.1 M | 9.93 M | 7.06 M | 7.22 M |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
132 M | 7.06 M | 71.2 M |
Quarterly General and Administrative Expenses Agios Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
38.5 M | 35.5 M | 31 M | - | 25.8 M | 30.4 M | 28.4 M | - | 29.1 M | 28.3 M | 31.5 M | - | 27.2 M | 29.2 M | 33.6 M | - | 28.3 M | 29.2 M | 31.7 M | - | 33 M | 32.4 M | 31.8 M | - | 31.1 M | 26.6 M | 24.6 M | - | 17.5 M | 16.1 M | 14.8 M | - | 11.9 M | 12.6 M | 10.8 M | - | 9.93 M | 8.93 M | 6.95 M | - | 5.17 M | 4.16 M | 3.29 M | - | 2.53 M | 1.84 M | 1.85 M | - | 1.58 M | 1.95 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
38.5 M | 1.58 M | 20.2 M |